Stanczak et al.12 have reported the upregulation of SIGLECs including SIGLEC9 on tumor-infiltrating T cells from non-small cell lung cancer, colorectal cancer, and ovarian cancer. This evidence concerns the gene SIGLEC9 and neoplasm.